0
Nov 17 (Reuters) – IMPACT Therapeutics, Inc: * EUROPEAN COMMISSION APPROVES SENAPARIB FOR MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)